J Korean Ophthalmol Soc > Volume 50(3); 2009 > Article
Journal of the Korean Ophthalmological Society 2009;50(3):412-417.
DOI: https://doi.org/10.3341/jkos.2009.50.3.412    Published online March 15, 2009.
The Effect of the Concurrent Therapy of Glucosamine and Aspirin in Uveitis.
Ji Eun Keum, Won Kyung Song, Joon Hong Son, Sung Chul Lee
1Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. sunglee@yuhs.ac
2Hankil Eye Hospital, Incheon, Korea.
포도막염에서 글루코자민과 아스피린 동시 투여의 효과
Department of Ophthalmology, Yonsei University College of Medicine1, Seoul, Korea / Hankil Eye Hospital2, Incheon, Korea
To report the anti-inflammatory effect and best-corrected visual acuity (BCVA) response after oral glucosamine (Glucosamine Sulfate 750(R), General Nutrition Companies, Inc.) and aspirin (Aspirin protect(R), Bayer) therapy in patients with uveitis. METHODS: Twenty-seven patients (43 eyes) with uveitis, not easily managed with conventional therapy, were treated with oral glucosamine 750 mg and aspirin 100 mg daily, and underwent BCVA testing and slit-lamp examination of anterior chamber inflammation. Changes in the dose of previously-used oral steroids and immunosuppressants were recorded at baseline, every 2 weeks for the first 2 months, and once every month thereafter. RESULTS: The mean follow-up period was 15.0+/-3.69 weeks and inflammation started to improve within 4.6 weeks. The change in visual acuity was not statistically significant, but grade of inflammation decreased by as much as 1.02+/-1.28, significantly (p<0.01) after treatment. In 12 patients (19 eyes, 44.2%) the dosage of systemic steroids and immunosuppressants could be Reduced. 7 patients (10 eyes, 23.3%) experienced aggravation of uveitis and the dosage of glucosamine and aspirin was increased. CONCLUSIONS: Concurrent oral administration of glucosamine and aspirin could not completely inhibit the recurrence of inflammation nor control it, but consistent use of these drugs may help to reduce inflammation without serious side effects. A longer prospective control study with larger sample size is required to further evaluation of the efficacy of the medication.
Key Words: Aspirin;Glucosamine;Inflammation;Uveitis

Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next